Diclofenac Sodium Topical Solution USP — Class II drug recall D-0259-2022
Terminated recall by Teligent Pharma, Inc., reported 2021-12-01, distributed nationwide. Defective Container
| Recall number | D-0259-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teligent Pharma, Inc., Buena, NJ, United States |
| Recall initiated | 2021-10-19 |
| Classified | 2021-11-23 |
| Reported by FDA | 2021-12-01 |
| Terminated | 2024-06-18 |
| Distributed | Nationwide (US) |
| Quantity | 5,400 units |
| Reason classes | packaging |
| NDC | 70512-0025-05 |
| Lot numbers | 15028, 15379 |
| Expiration dates | 2023-01, 2023-03 |
Product
Diclofenac Sodium Topical Solution USP, 1.5 w/w, 5 fl oz (150 mL) plastic bottles, Rx only, Teligent Pharma, Inc., Buena, New Jersey, 08310, NDC 70512-025-05.
Reason for recall
Defective Container
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0259-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.